ArticlePloS one2010
Potential benefits, limitations and target product-profiles of odor-baited mosquito traps for malaria control in Africa.
Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 82 citations in OpenAlex.
- A randomized, double-blind placebo-control study assessing the protective efficacy of an odour-based 'push-pull' malaria vector control strategy in reducing human-vector contact.Scientific reports · 2023Trial
- Trial
- The importance of considering community-level effects when selecting insecticidal malaria vector products.Parasites & vectors · 2011Trial
- Outdoor biting by malaria vectors: what are the options for intervention?Malaria journal · 2025Review
- The MTego trap: a potential tool for monitoring malaria and arbovirus vectors.Parasites & vectors · 2023Article
- The Shockwè trap: a human-baited exposure-free device for surveillance and behaviour studies of anthropophilic vectors.Wellcome open research · 2023Article
- A statistical calibration tool for methods used to sample outdoor-biting mosquitoes.Parasites & vectors · 2022Article
- Using ecological observations to improve malaria control in areas where Anopheles funestus is the dominant vector.Malaria journal · 2022Review
- Modelling Sand FlyMicroorganisms · 2021Article
- Predicting the impact of outdoor vector control interventions on malaria transmission intensity from semi-field studies.Parasites & vectors · 2021Article
- The fabric of life: what if mosquito nets were durable and widely available but insecticide-free?Malaria journal · 2020Review
- Creating mosquito-free outdoor spaces using transfluthrin-treated chairs and ribbons.Malaria journal · 2020Article
- Eave ribbons treated with transfluthrin can protect both users and non-users against malaria vectors.Malaria journal · 2019Article
- Evaluation of an ultraviolet LED trap for catching Anopheles and Culex mosquitoes in south-eastern Tanzania.Parasites & vectors · 2019Article
- Evaluation of a push-pull system consisting of transfluthrin-treated eave ribbons and odour-baited traps for control of indoor- and outdoor-biting malaria vectors.Malaria journal · 2019Article
- Reshaping the vector control strategy for malaria elimination in Ethiopia in the context of current evidence and new tools: opportunities and challenges.Malaria journal · 2018Review
- Malaria Modeling in the Era of Eradication.Cold Spring Harbor perspectives in medicine · 2017Review
- Small-scale field evaluation of push-pull system against early- and outdoor-biting malaria mosquitoes in an area of high pyrethroid resistance in Tanzania.Wellcome open research · 2017Article
- Attacking the mosquito on multiple fronts: Insights from the Vector Control Optimization Model (VCOM) for malaria elimination.PloS one · 2017Article
- Semi-field assessment of the BG-Malaria trap for monitoring the African malaria vector, Anopheles arabiensis.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
Abstract
backgroundTraps baited with synthetic human odors have been proposed as suitable technologies for controlling malaria and other mosquito-borne diseases. We investigated the potential benefits of such traps for preventing malaria transmission in Africa and the essential characteristics that they should possess so as to be effective. METHODS AND PRINCIPAL
findingsAn existing mathematical model was reformulated to distinguish availability of hosts for attack by mosquitoes from availability of blood per se. This adaptation allowed the effects of pseudo-hosts such as odor-baited mosquito traps, which do not yield blood but which can nonetheless be attacked by the mosquitoes, to be simulated considering communities consisting of users and non-users of insecticide-treated nets (ITNs), currently the primary malaria prevention method. We determined that malaria transmission declines as trap coverage (proportion of total availability of all hosts and pseudo hosts that traps constitute) increases. If the traps are more attractive than humans and are located in areas where mosquitoes are most abundant, 20-130 traps per 1000 people would be sufficient to match the impact of 50% community-wide ITN coverage. If such traps are used to complement ITNs, malaria transmission can be reduced by 99% or more in most scenarios representative of Africa. However, to match cost-effectiveness of ITNs, the traps delivery, operation and maintenance would have to cost a maximum of US$4.25 to 27.61 per unit per year. CONCLUSIONS AND SIGNIFICANCE: Odor-baited mosquito traps might potentially be effective and affordable tools for malaria control in Africa, particularly if they are used to complement, rather than replace, existing methods. We recommend that developers should focus on super-attractive baits and cheaper traps to enhance cost-effectiveness, and that the most appropriate way to deploy such technologies is through vertical delivery mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.